Mark Lamet

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety

David A. Johnson, Stanley B. Benjamin, Nimish Vakil et al. · The American Journal of Gastroenterology · 2001 · 159 citations

Medicine, Clinical Sciences, Pharmacotherapy +12

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green et al. · Gastroenterology · 2016 · 135 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis

Mark Lamet · Digestive Diseases and Sciences · 2010 · 53 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Safety and Efficacy of a New 3.3 g b.i.d. Tablet Formulation in Patients With Mild-to-Moderately-Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Ellen Scherl, Ronald E. Pruitt, Glenn L. Gordon et al. · The American Journal of Gastroenterology · 2009 · 48 citations

Medicine, Pharmacology, Pharmacotherapy +14

Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss

Abhishek Agnihotri, Amy Xie, Christopher R. Bartalos et al. · Clinical Gastroenterology and Hepatology · 2018 · 44 citations

Medicine, Internal Medicine, Gastroenterology +10